Published in Nat Rev Microbiol on October 02, 2006
Avian influenza virus (H5N1): a threat to human health. Clin Microbiol Rev (2007) 6.38
Mechanisms of GII.4 norovirus persistence in human populations. PLoS Med (2008) 4.57
Recent avian H5N1 viruses exhibit increased propensity for acquiring human receptor specificity. J Mol Biol (2008) 3.00
Immunization by avian H5 influenza hemagglutinin mutants with altered receptor binding specificity. Science (2007) 2.95
Quantitative biochemical rationale for differences in transmissibility of 1918 pandemic influenza A viruses. Proc Natl Acad Sci U S A (2008) 2.77
Influenza hemagglutinin and neuraminidase membrane glycoproteins. J Biol Chem (2010) 2.65
Opportunities and challenges in synthetic oligosaccharide and glycoconjugate research. Nat Chem (2009) 2.09
Glycan microarrays for decoding the glycome. Annu Rev Biochem (2011) 1.81
Mass spectrometry and the emerging field of glycomics. Chem Biol (2008) 1.69
A single base-pair change in 2009 H1N1 hemagglutinin increases human receptor affinity and leads to efficient airborne viral transmission in ferrets. PLoS One (2011) 1.43
Quantifiable fluorescent glycan microarrays. Glycoconj J (2007) 1.39
Glycans as receptors for influenza pathogenesis. Glycoconj J (2010) 1.38
Glycan microarray of Globo H and related structures for quantitative analysis of breast cancer. Proc Natl Acad Sci U S A (2008) 1.33
Sialic acids in the brain: gangliosides and polysialic acid in nervous system development, stability, disease, and regeneration. Physiol Rev (2014) 1.32
Distinct glycan topology for avian and human sialopentasaccharide receptor analogues upon binding different hemagglutinins: a molecular dynamics perspective. J Mol Biol (2009) 1.27
A human-infecting H10N8 influenza virus retains a strong preference for avian-type receptors. Cell Host Microbe (2015) 1.26
Influenza virus neuraminidases with reduced enzymatic activity that avidly bind sialic Acid receptors. J Virol (2012) 1.25
Recognition of sialylated poly-N-acetyllactosamine chains on N- and O-linked glycans by human and avian influenza A virus hemagglutinins. Angew Chem Int Ed Engl (2012) 1.23
Decoding the distribution of glycan receptors for human-adapted influenza A viruses in ferret respiratory tract. PLoS One (2012) 1.21
Receptor specificity of influenza A H3N2 viruses isolated in mammalian cells and embryonated chicken eggs. J Virol (2010) 1.21
Determinants of glycan receptor specificity of H2N2 influenza A virus hemagglutinin. PLoS One (2010) 1.20
Structure and receptor binding of the hemagglutinin from a human H6N1 influenza virus. Cell Host Microbe (2015) 1.19
Influenza A penetrates host mucus by cleaving sialic acids with neuraminidase. Virol J (2013) 1.19
Glyconanomaterials: synthesis, characterization, and ligand presentation. Adv Mater (2010) 1.17
Photoinitiated coupling of unmodified monosaccharides to iron oxide nanoparticles for sensing proteins and bacteria. Bioconjug Chem (2009) 1.16
Human parainfluenza viruses hPIV1 and hPIV3 bind oligosaccharides with alpha2-3-linked sialic acids that are distinct from those bound by H5 avian influenza virus hemagglutinin. J Virol (2007) 1.15
Networks link antigenic and receptor-binding sites of influenza hemagglutinin: mechanistic insight into fitter strain propagation. Sci Rep (2011) 1.14
The challenge and promise of glycomics. Chem Biol (2014) 1.13
The sweet spot: defining virus-sialic acid interactions. Nat Rev Microbiol (2014) 1.13
Differential carbohydrate recognition by Campylobacter jejuni strain 11168: influences of temperature and growth conditions. PLoS One (2009) 1.13
H5N1 receptor specificity as a factor in pandemic risk. Virus Res (2013) 1.11
Connecting the study of wild influenza with the potential for pandemic disease. Infect Genet Evol (2013) 1.08
Hemagglutinin receptor specificity and structural analyses of respiratory droplet-transmissible H5N1 viruses. J Virol (2013) 1.08
Binding of avian coronavirus spike proteins to host factors reflects virus tropism and pathogenicity. J Virol (2011) 1.04
Sialic acid recognition is a key determinant of influenza A virus tropism in murine trachea epithelial cell cultures. Virology (2009) 1.02
Chemoenzymatic synthesis of glycosaminoglycans: re-creating, re-modeling and re-designing nature's longest or most complex carbohydrate chains. Glycobiology (2013) 1.00
Glycomic analysis: an array of technologies. ACS Chem Biol (2009) 1.00
Sialic acid tissue distribution and influenza virus tropism. Influenza Other Respir Viruses (2008) 1.00
Viral tropism and the pathogenesis of influenza in the Mammalian host. Am J Pathol (2007) 1.00
Context-specific target definition in influenza a virus hemagglutinin-glycan receptor interactions. Chem Biol (2009) 0.99
Changes in the hemagglutinin of H5N1 viruses during human infection--influence on receptor binding. Virology (2013) 0.98
Receptor binding profiles of avian influenza virus hemagglutinin subtypes on human cells as a predictor of pandemic potential. J Virol (2010) 0.97
Partial direct contact transmission in ferrets of a mallard H7N3 influenza virus with typical avian-like receptor specificity. Virol J (2009) 0.97
Viral factors in influenza pandemic risk assessment. Elife (2016) 0.94
Innate immunity to H5N1 influenza viruses in humans. Viruses (2012) 0.94
Evolution of the hemagglutinin protein of the new pandemic H1N1 influenza virus: maintaining optimal receptor binding by compensatory substitutions. J Virol (2013) 0.94
Shotgun glycomics of pig lung identifies natural endogenous receptors for influenza viruses. Proc Natl Acad Sci U S A (2014) 0.93
Fluorescent labeling agents change binding profiles of glycan-binding proteins. Mol Biosyst (2011) 0.93
Influenza virus receptor specificity: disease and transmission. Am J Pathol (2010) 0.92
New-generation screening assays for the detection of anti-influenza compounds targeting viral and host functions. Antiviral Res (2013) 0.92
Sialidase specificity determined by chemoselective modification of complex sialylated glycans. ACS Chem Biol (2012) 0.92
Multiplexed, rapid detection of H5N1 using a PCR-free nanoparticle-based genomic microarray assay. BMC Biotechnol (2010) 0.90
Characterization of influenza hemagglutinin interactions with receptor by NMR. PLoS One (2012) 0.90
Harnessing glycomics technologies: integrating structure with function for glycan characterization. Electrophoresis (2012) 0.89
Quantitative characterization of glycan-receptor binding of H9N2 influenza A virus hemagglutinin. PLoS One (2013) 0.88
Blood Groups in Infection and Host Susceptibility. Clin Microbiol Rev (2015) 0.88
Bishydrazide glycoconjugates for lectin recognition and capture of bacterial pathogens. Bioconjug Chem (2010) 0.87
Global comparisons of lectin-glycan interactions using a database of analyzed glycan array data. Mol Cell Proteomics (2013) 0.87
Fabrication of glyconanoparticle microarrays. Anal Chem (2012) 0.87
Glycomics-based analysis of chicken red blood cells provides insight into the selectivity of the viral agglutination assay. FEBS J (2011) 0.87
Modulation of cellular adhesion by glycoengineering. J Med Chem (2010) 0.86
Glycan receptor specificity as a useful tool for characterization and surveillance of influenza A virus. Trends Microbiol (2014) 0.86
Chemistry of natural glycan microarrays. Curr Opin Chem Biol (2014) 0.86
Glycoprotein analysis using protein microarrays and mass spectrometry. Mass Spectrom Rev (2010) 0.86
Determination of receptor specificities for whole influenza viruses using multivalent glycan arrays. Chem Commun (Camb) (2015) 0.86
Carbohydrate cluster microarrays fabricated on three-dimensional dendrimeric platforms for functional glycomics exploration. J Proteome Res (2009) 0.85
Glycans and glycan-binding proteins in immune regulation: A concise introduction to glycobiology for the allergist. J Allergy Clin Immunol (2015) 0.84
Cell receptors for influenza a viruses and the innate immune response. Front Microbiol (2012) 0.84
Photogenerated carbohydrate microarrays to study carbohydrate-protein interactions using surface plasmon resonance imaging. Biosens Bioelectron (2010) 0.84
Protein biomarkers in cancer: natural glycoprotein microarray approaches. Curr Opin Mol Ther (2008) 0.84
Modulation of glycan detection on specific glycoproteins by lectin multimerization. Anal Chem (2013) 0.84
Use of ex vivo and in vitro cultures of the human respiratory tract to study the tropism and host responses of highly pathogenic avian influenza A (H5N1) and other influenza viruses. Virus Res (2013) 0.83
Nanoscale clustering of carbohydrate thiols in mixed self-assembled monolayers on gold. Langmuir (2012) 0.82
Derivatization of free natural glycans for incorporation onto glycan arrays: derivatizing glycans on the microscale for microarray and other applications (ms# CP-10-0194). Curr Protoc Chem Biol (2011) 0.82
Oxidative release of natural glycans for functional glycomics. Nat Methods (2016) 0.81
Recent H3N2 Viruses Have Evolved Specificity for Extended, Branched Human-type Receptors, Conferring Potential for Increased Avidity. Cell Host Microbe (2016) 0.81
Signal amplification of target protein on heparin glycan microarray. Anal Biochem (2008) 0.81
The influenza A segment 7 mRNA 3' splice site pseudoknot/hairpin family. RNA Biol (2012) 0.81
Novel cleavage of reductively aminated glycan-tags by N-bromosuccinimide to regenerate free, reducing glycans. ACS Chem Biol (2013) 0.80
Direct sequence detection of structured h5 influenza viral RNA. J Mol Diagn (2008) 0.80
Integrated Omics and Computational Glycobiology Reveal Structural Basis for Influenza A Virus Glycan Microheterogeneity and Host Interactions. Mol Cell Proteomics (2016) 0.80
Modular glycosphere assays for high-throughput functional characterization of influenza viruses. BMC Biotechnol (2013) 0.80
Parallel chemoenzymatic synthesis of sialosides containing a C5-diversified sialic acid. Bioorg Med Chem Lett (2009) 0.80
Signal amplification by glyco-qPCR for ultrasensitive detection of carbohydrates: applications in glycobiology. Angew Chem Int Ed Engl (2012) 0.80
The detection and discovery of glycan motifs in biological samples using lectins and antibodies: new methods and opportunities. Adv Cancer Res (2015) 0.79
Glycomic Approaches for the Discovery of Targets in Gastrointestinal Cancer. Front Oncol (2016) 0.77
Association analyses of large-scale glycan microarray data reveal novel host-specific substructures in influenza A virus binding glycans. Sci Rep (2015) 0.76
Glycan based detection and drug susceptibility of influenza virus. Anal Chem (2014) 0.76
Glycomaterials for probing host-pathogen interactions and the immune response. Exp Biol Med (Maywood) (2016) 0.76
SugarBindDB, a resource of glycan-mediated host-pathogen interactions. Nucleic Acids Res (2015) 0.76
Sialylated immunoglobulin G can neutralize influenza virus infection through receptor mimicry. Oncotarget (2016) 0.75
Assessing Bacterial Interactions Using Carbohydrate-Based Microarrays. Microarrays (Basel) (2015) 0.75
Ab initio base fragment molecular orbital studies of influenza viral hemagglutinin HA1 full-domains in complex with sialoside receptors. J Mol Genet Med (2008) 0.75
Membrane environment can enhance the interaction of glycan binding protein to cell surface glycan receptors. ACS Chem Biol (2014) 0.75
Rapid preparation of mutated influenza hemagglutinins for influenza virus pandemic prevention. AMB Express (2016) 0.75
Phage escape libraries for checkmate analysis. Proc Natl Acad Sci U S A (2007) 0.75
Conformation and Linkage Studies of Specific Oligosaccharides Related to H1N1, H5N1, and Human Flu for Developing the Second Tamiflu. Biomol Ther (Seoul) (2014) 0.75
Antibody recognition of a highly conserved influenza virus epitope. Science (2009) 11.26
Broad neutralization coverage of HIV by multiple highly potent antibodies. Nature (2011) 11.07
Structure and receptor specificity of the hemagglutinin from an H5N1 influenza virus. Science (2006) 10.04
HIV vaccine design and the neutralizing antibody problem. Nat Immunol (2004) 9.48
Siglecs and their roles in the immune system. Nat Rev Immunol (2007) 7.98
The broadly neutralizing anti-human immunodeficiency virus type 1 antibody 2G12 recognizes a cluster of alpha1-->2 mannose residues on the outer face of gp120. J Virol (2002) 7.82
Structure of a V3-containing HIV-1 gp120 core. Science (2005) 7.69
How TCRs bind MHCs, peptides, and coreceptors. Annu Rev Immunol (2006) 7.57
Printed covalent glycan array for ligand profiling of diverse glycan binding proteins. Proc Natl Acad Sci U S A (2004) 7.55
Structure of HIV-1 gp120 V1/V2 domain with broadly neutralizing antibody PG9. Nature (2011) 7.20
Structure of the uncleaved human H1 hemagglutinin from the extinct 1918 influenza virus. Science (2004) 6.70
Antibody domain exchange is an immunological solution to carbohydrate cluster recognition. Science (2003) 6.68
Glycan microarray analysis of the hemagglutinins from modern and pandemic influenza viruses reveals different receptor specificities. J Mol Biol (2005) 6.17
Structural basis of preexisting immunity to the 2009 H1N1 pandemic influenza virus. Science (2010) 6.10
Structural genomics of the Thermotoga maritima proteome implemented in a high-throughput structure determination pipeline. Proc Natl Acad Sci U S A (2002) 6.00
A highly conserved neutralizing epitope on group 2 influenza A viruses. Science (2011) 5.66
Fine mapping of the interaction of neutralizing and nonneutralizing monoclonal antibodies with the CD4 binding site of human immunodeficiency virus type 1 gp120. J Virol (2003) 5.59
Crystal structure of a soluble cleaved HIV-1 envelope trimer. Science (2013) 5.53
Natural killer T cells recognize diacylglycerol antigens from pathogenic bacteria. Nat Immunol (2006) 5.51
A potent and broad neutralizing antibody recognizes and penetrates the HIV glycan shield. Science (2011) 5.44
A single amino acid substitution in 1918 influenza virus hemagglutinin changes receptor binding specificity. J Virol (2005) 4.71
Cryo-EM structure of a fully glycosylated soluble cleaved HIV-1 envelope trimer. Science (2013) 4.61
Computational design of proteins targeting the conserved stem region of influenza hemagglutinin. Science (2011) 4.42
Structures of the CCR5 N terminus and of a tyrosine-sulfated antibody with HIV-1 gp120 and CD4. Science (2007) 4.35
Broadly neutralizing anti-HIV antibody 4E10 recognizes a helical conformation of a highly conserved fusion-associated motif in gp41. Immunity (2005) 4.26
A next-generation cleaved, soluble HIV-1 Env trimer, BG505 SOSIP.664 gp140, expresses multiple epitopes for broadly neutralizing but not non-neutralizing antibodies. PLoS Pathog (2013) 4.23
Recapitulation of IVIG anti-inflammatory activity with a recombinant IgG Fc. Science (2008) 4.11
New world bats harbor diverse influenza A viruses. PLoS Pathog (2013) 4.10
Protein production and purification. Nat Methods (2008) 3.97
Crystal structure of human toll-like receptor 3 (TLR3) ectodomain. Science (2005) 3.72
Characterization of H7N9 influenza A viruses isolated from humans. Nature (2013) 3.71
Antibody vs. HIV in a clash of evolutionary titans. Proc Natl Acad Sci U S A (2005) 3.57
Rational HIV immunogen design to target specific germline B cell receptors. Science (2013) 3.55
Broadly neutralizing antibodies present new prospects to counter highly antigenically diverse viruses. Science (2012) 3.53
Neutralizing antibodies derived from the B cells of 1918 influenza pandemic survivors. Nature (2008) 3.47
Highly conserved protective epitopes on influenza B viruses. Science (2012) 3.47
Contemporary North American influenza H7 viruses possess human receptor specificity: Implications for virus transmissibility. Proc Natl Acad Sci U S A (2008) 3.45
Exploration of uncharted regions of the protein universe. PLoS Biol (2009) 3.41
Structural rationale for the broad neutralization of HIV-1 by human monoclonal antibody 447-52D. Structure (2004) 3.31
A Blueprint for HIV Vaccine Discovery. Cell Host Microbe (2012) 3.27
Vaccination with a synthetic peptide from the influenza virus hemagglutinin provides protection against distinct viral subtypes. Proc Natl Acad Sci U S A (2010) 3.24
A dynamic knockout reveals that conformational fluctuations influence the chemical step of enzyme catalysis. Science (2011) 3.19
In vitro evolution of H5N1 avian influenza virus toward human-type receptor specificity. Virology (2011) 3.19
Structure and function of a potent agonist for the semi-invariant natural killer T cell receptor. Nat Immunol (2005) 3.12
Supersite of immune vulnerability on the glycosylated face of HIV-1 envelope glycoprotein gp120. Nat Struct Mol Biol (2013) 3.11
Crystal structure of a bacterial cocaine esterase. Nat Struct Biol (2002) 3.06
Recent avian H5N1 viruses exhibit increased propensity for acquiring human receptor specificity. J Mol Biol (2008) 3.00
Asymmetric recognition of the HIV-1 trimer by broadly neutralizing antibody PG9. Proc Natl Acad Sci U S A (2013) 2.96
Replication and transmission of H9N2 influenza viruses in ferrets: evaluation of pandemic potential. PLoS One (2008) 2.86
Structural basis for distinct ligand-binding and targeting properties of the receptors DC-SIGN and DC-SIGNR. Nat Struct Mol Biol (2004) 2.83
Genetic and phenotypic analyses of human immunodeficiency virus type 1 escape from a small-molecule CCR5 inhibitor. J Virol (2004) 2.80
HIV-1 and influenza antibodies: seeing antigens in new ways. Nat Immunol (2009) 2.80
Structure and function of broadly reactive antibody PG16 reveal an H3 subdomain that mediates potent neutralization of HIV-1. Proc Natl Acad Sci U S A (2010) 2.77
Broadly neutralizing antibody PGT121 allosterically modulates CD4 binding via recognition of the HIV-1 gp120 V3 base and multiple surrounding glycans. PLoS Pathog (2013) 2.66
Structural characterization of the 1918 influenza virus H1N1 neuraminidase. J Virol (2008) 2.63
T cell activation by lipopeptide antigens. Science (2004) 2.59
Sweet spots in functional glycomics. Nat Chem Biol (2006) 2.50
Dissection of the carbohydrate specificity of the broadly neutralizing anti-HIV-1 antibody 2G12. Proc Natl Acad Sci U S A (2005) 2.50
A general strategy for the chemoenzymatic synthesis of asymmetrically branched N-glycans. Science (2013) 2.49
High-efficiency labeling of sialylated glycoproteins on living cells. Nat Methods (2009) 2.46
Cross-neutralization of influenza A viruses mediated by a single antibody loop. Nature (2012) 2.44
Trimeric HIV-1 glycoprotein gp140 immunogens and native HIV-1 envelope glycoproteins display the same closed and open quaternary molecular architectures. Proc Natl Acad Sci U S A (2011) 2.38
Three-dimensional structural view of the central metabolic network of Thermotoga maritima. Science (2009) 2.33
Effect of receptor binding domain mutations on receptor binding and transmissibility of avian influenza H5N1 viruses. Virology (2011) 2.28
Tafamidis, a potent and selective transthyretin kinetic stabilizer that inhibits the amyloid cascade. Proc Natl Acad Sci U S A (2012) 2.27
XtalPred: a web server for prediction of protein crystallizability. Bioinformatics (2007) 2.26
The molecular interaction of CAR and JAML recruits the central cell signal transducer PI3K. Science (2010) 2.26
Glycan array screening reveals a candidate ligand for Siglec-8. J Biol Chem (2004) 2.24
Homomultimeric complexes of CD22 in B cells revealed by protein-glycan cross-linking. Nat Chem Biol (2005) 2.22
Crystal structure of CD1a in complex with a sulfatide self antigen at a resolution of 2.15 A. Nat Immunol (2003) 2.20
Structural basis for CD1d presentation of a sulfatide derived from myelin and its implications for autoimmunity. J Exp Med (2005) 2.18
In vivo targeting of B-cell lymphoma with glycan ligands of CD22. Blood (2010) 2.17
Optimization of affinity, specificity and function of designed influenza inhibitors using deep sequencing. Nat Biotechnol (2012) 2.14
Comparative efficacy of neutralizing antibodies elicited by recombinant hemagglutinin proteins from avian H5N1 influenza virus. J Virol (2008) 2.14
Structural basis of steroid hormone perception by the receptor kinase BRI1. Nature (2011) 2.12
Structural basis of TLR5-flagellin recognition and signaling. Science (2012) 2.10
Contrasting IgG structures reveal extreme asymmetry and flexibility. J Mol Biol (2002) 2.10
Cleavage strongly influences whether soluble HIV-1 envelope glycoprotein trimers adopt a native-like conformation. Proc Natl Acad Sci U S A (2013) 2.10
Frontiers in glycomics: bioinformatics and biomarkers in disease. An NIH white paper prepared from discussions by the focus groups at a workshop on the NIH campus, Bethesda MD (September 11-13, 2006). Proteomics (2008) 2.09
Glycomics: an integrated systems approach to structure-function relationships of glycans. Nat Methods (2005) 2.06
Mouse Siglec-F and human Siglec-8 are functionally convergent paralogs that are selectively expressed on eosinophils and recognize 6'-sulfo-sialyl Lewis X as a preferred glycan ligand. Glycobiology (2005) 2.06
Hepatitis C virus E2 envelope glycoprotein core structure. Science (2013) 2.06
Outcome of a workshop on applications of protein models in biomedical research. Structure (2009) 2.05
Cell surface biology mediated by low affinity multivalent protein-glycan interactions. Curr Opin Chem Biol (2004) 2.05
Siglecs as targets for therapy in immune-cell-mediated disease. Trends Pharmacol Sci (2009) 2.04